Te Pātaka Whaioranga - Pharmac is in the process of drafting its next annual invitation to tender (ITT) for supply of pharmaceuticals to Te Whatu Ora Hospitals and/or Community Pharmacies.
The Pharmac ITT is an annual open competitive procurement process. It gives suppliers the opportunity to bid for supply of a large range of different medicines and related products (approximately 400–700 line items per tender).
Suppliers bid to have “Principal Supply Status” on medicines and related products included in the ITT. If awarded a tender, the supplier’s brand becomes the main funded brand in the community and/or Te Whatu Ora Hospitals. The principal supplier is guaranteed up to 95% of the total funded market until 30 June 2027.
Pharmac consults on its draft Annual ITT every year in July/August. Through this process there is also an opportunity for suppliers to submit Alternative Commercial Proposals. Find out more about this here:
Pharmac generally includes pharmaceuticals that:
• are currently under a tender agreement, but the exclusive supply period of the agreement is about to expire
• are coming off patent
• have subsidy or delisting protections that are ending soon
• have new competition.
The finalised Annual ITT is released every year in October/November.
Attached to this FPO is information from the Pharmaceutical Schedule that includes detail on when currently active exclusive supply arrangements are ending. Products where exclusive supply arrangements are ending soon (eg in 2023 or 2024) might be considered for inclusion in this year’s annual ITT. We welcome suppliers to get in touch about products they may be interested in supplying now or when the draft ITT is released for consultation.
Other useful links:
Previous Annual Tenders issued:
Final 2022/2023 ITT: https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/tender-2022-10-31-itt
Final 2021/22 ITT: https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/tender-2021-11-01-itt
Final 2020/21 ITT: https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/tender-2020-11-02-itt
Please view the Pharmaceutical Schedule for information on funded pharmaceuticals:
Indicative RFx Release Date: Q4 2023
Project Status: Initial development
Indicative Total Value: $100M +
|Closing||1 Nov 2023 12:00 PM NZDT|
|Notice Type||Future Contract Opportunities (FCO)|
|Contact Details||Pharmac Tender Team
|Published||1 Apr 2023 12:00 AM NZDT|